Yahoo Web Search

Search results

    • Insmed's lung disease drug succeeds in late-stage study

      Reuters via Yahoo News· 1 day ago

      Data from 1,680 adult and 41 adolescent patients with non-cystic fibrosis bronchiectasis also showed the drug, brensocatib, was safe and well-tolerated at the two tested dosages, 10 milligrams ...